DAILY MORNING NOTE | 19 May 2023

SINGAPORE shares finished higher on Thursday (May 18) alongside major regional peers, tracking overnight gains on Wall Street as fears abated over the US debt ceiling crisis with talks progressing. Singapore shares inched up 8.71 points or 0.3 per cent to 3,182.55, following gains in US stocks after the Biden administration said that a deal on raising the debt ceiling could be reached as soon as this week. Key gauges across the region rose, from Japan – a clear outperformer – Hong Kong and Taiwan to China, South Korea, Malaysia and Australia.

ALL three major US stock-market indexes closed higher on Thursday following better-than-expected earnings results for Walmart and optimism over the future profitability of artificial intelligence (AI). The tech-rich Nasdaq Composite Index ended the day up more than 1.5 per cent at 12,688.84. The broad-based S&P 500 gained 0.9 per cent to 4,198.05, while The Dow Jones Industrial Average finished up 0.3 per cent to 33,535.91.

Top gainers & losers

Factsheets



EVENTS THIS WEEK

Factsheets

SG

Singapore and Kenya have agreed to ratify a bilateral investment treaty and an avoidance of double taxation agreement that had been signed earlier, paving the way for greater trade and investment activity between the two countries.

GRAB reported a loss of US$250 million in Q1 2023, narrowing from US$435 million in Q1 2022.This comes on the back of lower net interest expenses and improved group adjusted earnings before interest, taxes, depreciation and amortisation (Ebitda) Revenue rose 130 per cent in Q1 2023 to US$525 million from US$228 million in the year before. This was attributed to growth across all business segments, reduction in incentives and a change in business model for certain delivery offerings in one of its markets. Without the change in business model, Q1 2023’s revenue growth would have been 50 per cent year on year.

JARDINE Matheson Holdings (JMH) said in an interim management statement on Thursday (May 18) that it had achieved a “strong overall performance” in the first quarter of the year ended March, but warned that challenges remain from the global economic environment and softening commodity prices.

NetLink NBN Trust on Thursday (May 18) reported earnings of S$54.7 million for the second half of its fiscal year ended March, up 6.9 per cent from S$51.2 million in the corresponding year-ago period. With the stronger bottom-line showing, the company sweetened its distribution payout to shareholders, doling out a record-high total full-year distribution of S$0.0524 per unit for FY2023.


US

OIL prices slid about 1 per cent on Thursday after solid US economic data spurred the dollar to reach a two-month high on growing expectations the US Federal Reserve could raise interest rates again in June. Brent futures fell US$1.10, or 1.4 per cent, to settle at US$75.86 a barrel. US West Texas Intermediate (WTI) crude fell 97 cents, or 1.3 per cent, to settle at US$71.86. The US dollar rose to its highest since March 17 against a basket of currencies on data showing lower-than-expected initial jobless claims and optimism about a possible debt ceiling deal.

THE US Supreme Court on Thursday (May 18) refused to clear a path for victims of attacks by militant organisations to hold social media companies liable under an anti-terrorism law for failing to stop the groups from using their platforms, handing a victory to Twitter.

APPLE has lowered sales estimates for its long-awaited mixed-reality headsets by about two-thirds, Bloomberg News reported on Thursday (May 18), citing people familiar with the matter. The iPhone-maker had initially hoped to sell about 3 million units a year, but has now pared back those estimates to about 1 million, and then to 900,000 units, the report said. The headset is expected to cost around US$3,000. Meta Platform’s Quest Pro virtual and mixed reality headset is priced at about US$1,000.

BLACKSTONE president Jon Gray said last month that private credit is having a “golden moment” as fund managers take advantage of tighter credit after recent banking turmoil. Left unsaid was that a big push in Europe is proving an exception. Almost six months after starting a fund targeting the region’s wealthy, the firm’s figures show it’s amassed 240 million euros (S$348.7 million) for the product – through investor commitments and fund leverage – which is designed to provide alternative financing for private equity buyout deals. It’s a paltry amount compared with the US$12 billion raised for an equivalent US fund, dubbed BCRED, at the half-year point.


Source: SGX Masnet, Bloomberg, Channel NewsAsia, Reuters, CNBC, WSJ, The Business Times, PSR


RESEARCH REPORTS

Hyphens Pharma International – Disruption in specialty pharma supply

Recommendation: BUY (Maintained); TP S$0.39 Last close: S$0.28; Analyst Paul Chew

– 1Q23 results were below expectations. Revenue and PATMI were 19%/10% of our forecasts. Revenue suffered from the cessation of Biosensors and delay shipments in Vietnam.

– Specialty pharma revenue declined by 27%. The loss of Biosensor distribution in Dec 22 was well flagged. The surprise was supply disruption from three specialty pharma manufacturers.

– We cut our FY23e earnings by 31% to S$9.1mn and the DCF target price is lowered to S$0.39 (prev. S$0.445). Our BUY recommendation is maintained. We expect the supply constraints to spill over into 2Q23. Proprietary brands have performed well with 16% growth. It will be a multi-year journey for proprietary brands to reach scale and compete even more effectively in the region. Investments into DocMed, another $5.4mn over the next 2-3 years could drag earnings but can be deemed as one-off upfront cost to develop the platform.

PSR Stocks Coverage

Factsheets


Factsheets


For more information, please visit:

https://www.stocksbnb.com/singapore-stocks-coverage/


Upcoming Webinars

Guest Presentation by LHN Limited [NEW]

Date: 26 May 2023

Time: 12pm – 1pm

Register: https://bit.ly/44XPNdk


Guest Presentation by Sunview Group Berhad [NEW]

Date: 1 June 2023

Time: 12pm – 1pm

Register: https://bit.ly/3LUwZme


Guest Presentation by Power Integrations [NEW]

Date: 14 June 2023

Time: 8.30pm – 9.30pm

Register: https://bit.ly/3IoPTkt


Guest Presentation by United Hampshire US REIT [NEW]

Date: 28 June 2023

Time: 7pm – 8pm

Register: https://bit.ly/3pIRkUl


POEMS Podcast:

Research Videos

Weekly Market Outlook: OCBC, Block Inc., PayPal, Alphabet, META, SG Banking, SG Weekly & More!
Date: 15 May 2023
Click here for more on Market Outlook.
Sign up for our webinars here, and be among the first to receive economy and market updates.

PHILLIP RESEARCH IN 3 MINS

Phillip Research in 3 minutes: #29 Keppel Corporation; Initiation
Click here for more on Phillip in 3 mins.

Follow our Socials

Facebook Social Icon Instagram Icon Twitter Social Icon Youtube Social Icon Linkedin Social Icon TikTok Social Icon Spotify Social Icon

Join our Singapore Equity Research Community on POEMS Mobile 3 App for the latest research reports, market updates, insights and more

Click to join!

Disclaimer

The information contained in this email and/or its attachment(s) is provided to you for information only and is not intended to or nor will it create/induce the creation of any binding legal relations. The information or opinions provided in this email do not constitute an investment advice, an offer or solicitation to subscribe for, purchase or sell the e investment product(s) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of this information. Investments are subject to investment risks including possible loss of the principal amount invested. The value of the product and the income from them may fall as well as rise. You may wish to seek advice from an independent financial adviser before making a commitment to purchase or investing in the investment product(s) mentioned herein. In the event that you choose not to do so, you should consider whether the investment product(s) mentioned herein is suitable for you. PhillipCapital and any of its members will not, in any event, be liable to you for any direct/indirect or any other damages of any kind arising from or in connection with your reliance on any information in and/or materials attached to this email. The information and/or materials provided 揳s is?without warranty of any kind, either express or implied. In particular, no warranty regarding accuracy or fitness for a purpose is given in connection with such information and materials.

Confidentiality Note

This e-mail and its attachment(s) may contain privileged or confidential information, which is intended only for the use of the recipient(s) named above. If you have received this message in error, please notify the sender immediately and delete all copies of it. If you are not the intended recipient, you must not read, use, copy, store, disseminate and/or disclose to any person this email and any of its attachment(s). PhillipCapital and its members will not accept legal responsibility for the contents of this message. Thank you for your cooperation.

Contact us to Open an Account

Need Assistance? Share your Details and we’ll get back to you

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com